22
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Clinical efficacy and safety of augmented betamethasone dipropionate ointment and diflorasone diacetate ointment for psoriasis — a multicentre, randomized, double-blinded study

&
Pages 63-66 | Published online: 12 Jul 2009
 

Abstract

The clinical efficacy and safety of 0.5% augmented betamethasone dipropionate ointment (Diprolene) and 0.05% diflorasone diacetate ointment (Psorcon) were evaluated in a multicentre randomized double-blind trial. A total of 164 patients with psoriasis from four geographic regions of the US were treated in this 2-week clinical study. One half received Diprolene ointment and the other half, Psorcon. After 2 weeks, both ointments significantly improved psoriasis (p < 0.001), but Diprolene ointment held a slight, but significant, advantage over Psorcon ointment in clinical efficacy. There was a high patient preference for Diprolene ointment which led to fewer adverse reactions.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.